Ceftolozane/tazobactam for febrile UTI due to multidrug-resistant Pseudomonas aeruginosa in a patient with neurogenic bladder.

about

Ceftolozane/tazobactam for febrile UTI due to multidrug-resistant Pseudomonas aeruginosa in a patient with neurogenic bladder.

Item

http://www.wikidata.org/entity/Q40213320

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Ceftolozane/tazobactam for feb ...... tient with neurogenic bladder.

@en

type

Item

label

Ceftolozane/tazobactam for feb ...... tient with neurogenic bladder.

@en

prefLabel

Ceftolozane/tazobactam for feb ...... tient with neurogenic bladder.

@en

P1476

Ceftolozane/tazobactam for feb ...... atient with neurogenic bladder

@en

P2093

Anaïs Potron

http://www.w3.org/2001/XMLSchema#string

Aurélien Dinh

http://www.w3.org/2001/XMLSchema#string

Benjamin Davido

http://www.w3.org/2001/XMLSchema#string

Clara Duran

http://www.w3.org/2001/XMLSchema#string

Frédérique Bouchand

http://www.w3.org/2001/XMLSchema#string

Julie Paquereau

http://www.w3.org/2001/XMLSchema#string

Jérôme Salomon

http://www.w3.org/2001/XMLSchema#string

Martin Rottman

http://www.w3.org/2001/XMLSchema#string

Patrick Plésiat

http://www.w3.org/2001/XMLSchema#string

Ruxandra Calin

http://www.w3.org/2001/XMLSchema#string

P2860

Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination

Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America

Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.

Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001

Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).

Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia

Management of febrile urinary tract infection among spinal cord injured patients

Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.

Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia.

Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.

P2888

scsandc.2017.19

P304

17019

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1038/SCSANDC.2017.19

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Emmanuel Chartier-Kastler

P577

2017-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28503325

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

5425957

http://www.w3.org/2001/XMLSchema#string